Piramal Enterprises has received approval to raise up to Rs 650 crore by issuing bonds. The size of the issue is up to Rs 50 crore with an option to retain over subscription of up to Rs 600 crore. The meeting of administrative committee of the board of directors has clear the issuance of secured, rated, listed, redeemable, principal protected, market linked non-convertible debentures on private placement basis.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.